3Hamzeh N. Sarcoidosis. Med Clin North Am, 2011 , 95 : 1223-1234.
4Basu S, Zhuang H, Torigian DA, et al. Functional imaging ofinflammatory diseases using nuclear medicine techniques. SeminNucl Med, 2009, 39-.124-145.
5Teirstein AS, Machac J, Almeida 0,et al. Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137patients with sarcoidosis. Chest, 2007 , 132 : 1949-1953.
6Sobic-Saranovic D, Grozdic I,Videnovic-Ivanov J, et al. Theutility of 18F-FDG PET/CT for diagnosis and adjustment of therapyin patients with active chronic sarcoidosis. J Nucl Med, 2012, 53 :1543-1549.
7Mostard RL, Prompers L, Weijers RE, et al. F-18 FDG PET/CTfor detecting bone and bone marrow involvement in sarcoidosispatients. Clin Nucl Med, 2012, 37:21-25.
8Tannen BL, Ghesani NV, Frohman L, et al. Use of whole-bodyFDG PET-CT to aid in the diagnosis of occult sarcoidosis. OculImmunol Inflamm, 2008 , 16:25-27.
9Lewis PJ, Salama A. Uptake of fluorine-18-fluorodeoxyglucose insarcoidosis. J Nucl Med, 1994,35 : 1647-1649.
10Kumar A,Dutta R,Kannan U,et al. Evaluation of mediastinallymph nodes using F-FDG PET-CT scan and its histopathologiccorrelation. Ann Thorac Med, 2011,6:11-16.
